Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors

Rationale: PD1/PD-L1 immune checkpoint inhibitors have shown promising results for several malignancies. However, PD1/PD-L1 signaling and its therapeutic significance remains largely unknown in intrahepatic cholangiocarcinoma (ICC) cases with complex etiology. Methods: We investigated the expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jia-Cheng, Zeng, Hai-Ying, Sun, Qi-Man, Meng, Qing-Nan, Huang, Xiao-Yong, Zhang, Peng-Fei, Yang, Xuan, Peng, Rui, Gao, Chao, Wei, Chuan-Yuan, Shen, Ying-Hao, Cai, Jia-Bing, Dong, Rui-Zhao, Shi, Ying-Hong, Sun, Hui-Chuan, Shi, Yujiang G., Zhou, Jian, Fan, Jia, Ke, Ai-Wu, Yang, Liu-Xiao, Shi, Guo-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643449/
https://www.ncbi.nlm.nih.gov/pubmed/31367249
http://dx.doi.org/10.7150/thno.36276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643449/
https://www.ncbi.nlm.nih.gov/pubmed/31367249
http://dx.doi.org/10.7150/thno.36276

Ejemplares similares